InvestorsHub Logo

cintrix

02/16/22 9:07 AM

#314944 RE: cintrix #314943

SAGE now down 15% Wall Street raised questions about the durability of the experimental treatment for major depressive disorder that Sage is developing with Biogen Inc. .